Delivery of Protein Antigen to the Major Histocompatibility Complex Class I-Restricted Antigen Presentation Pathway

References

• Abdel Motal U. M., Zhou X., Joki A., Siddiqi A. R., Srinivasa B. R., Stenvall K., Jondal M. MHC class I binding peptides are recycled to the cell surface after internalization. Eur. J. Immunol. (1993); 23: 3224
   PubMed Web of Science ®Google Scholar
• Aichele P., Hengartner H., Zingernagel R. M., Schulz M. Antiviral cytotoxic T cell response induced by in vitro priming with a free synthetic peptide. J. Exp. Med. (1990); 171: 1815
   PubMed Web of Science ®Google Scholar
• Alving C. R. Liposomes as carriers of antigens and adjuvants. J. Immunol. Methods (1991); 140: 1
   PubMed Web of Science ®Google Scholar
• Arnold D., Driscoll J., Androlewicz M., Hughes E., Cresswell P., Spies T. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature (1992); 360: 171
   PubMed Web of Science ®Google Scholar
• Arnon R., Horwitz R. Synthetic peptides as vaccine. Current Opinion Immunol. (1992); 4: 449
   PubMed Web of Science ®Google Scholar
• Bakke O., Dobberstein B. MHC class II-associated invariant chain contains a strong signal for endocytic compartments. Cell (1990); 63: 707
   PubMed Web of Science ®Google Scholar
• Bass H. Z., Yamashita N., Clement L. T. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. J. Immunol. (1992); 149: 2489
   PubMed Web of Science ®Google Scholar
• Bevan M. J. Class discrimination in the world of Immunology. Nature (1987); 325: 192
   PubMed Web of Science ®Google Scholar
• Bjorkman P. J., Saper M. A., Samraoli B., Bennett W. S., Strominger J. L., Wiley D. C. The foreign antigen binding site and T cell recognition regions of class I MHC antigen. Nature (1987); 329: 512
   PubMed Web of Science ®Google Scholar
• Bowen J. C., Nair S. K., Reddy R., Rouse B. T. Cholera toxin acts as a potent adjuvant for the induction of CTL response with non-replicating antigens. Immunology (1994); 81: 338
   PubMed Web of Science ®Google Scholar
• Brown M. G., Driscoll J., Monaco J. J. Structural and serological similarity of MHC-linked LMP and proteasome complexes. Nature (1991); 353: 355
   PubMed Web of Science ®Google Scholar
• Brunt L. M., Portnoy D. A., Unanue E. R. Presentation of Listeria Monocytogens to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J. Immunol (1990); 145: 3540
   PubMed Web of Science ®Google Scholar
• Calin-Laurens V., Forquet F., Mottez E., Kanellopoulos J., Rabourdin-Combe C. Cytotoxic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II MHC molecules. Eur. J. Immunol. (1991); 21: 761
   PubMed Web of Science ®Google Scholar
• Carbone F. R., Bevan M. J. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. (1989); 169: 603
   Google Scholar
• Carbone F. R., Bevan M. J. Class I-restricted processing and presentation of exogenous cell associated antigen in vivo. J. Exp. Med. (1990); 171: 377
   PubMed Web of Science ®Google Scholar
• Celis J. E. Microinjection of somatic cells with micropipettes: comparison with other transfer techniques. Biochem. J. (1984); 223: 281
   PubMed Web of Science ®Google Scholar
• Cerundolo V., Alexander J., Anderson K., et al. Presentation of viral antigen controlled by the MHC. Nature (1990); 345: 449
   PubMed Web of Science ®Google Scholar
• Chavali S. R., Champbell J. B. Immunomodulatory effect of orally administered saponin on humoral and cellular immune responses in mice. Immunobiol. (1987); 174: 347
   PubMed Web of Science ®Google Scholar
• Chen W., Carbone F. R., McCluskey J. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway: Priming in vitro and in vivo for class I-restricted recognition of soluble antigen. J. Immunol. Methods (1993); 160: 49
   PubMed Web of Science ®Google Scholar
• Christinck E. R., Luscher M. A., Batber B. H., Williams D. B. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature (1991); 352: 67
   PubMed Web of Science ®Google Scholar
• Claassen E. Post-formation fluorescent labeling of liposomal membrane: in vivo detection, location and kinetics. J. Immunol. Methods (1992); 147: 231
   PubMed Web of Science ®Google Scholar
• Collins D., Huang L. Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway. Biochim. Biophys. Acta (1989); 987: 47
   PubMed Web of Science ®Google Scholar
• Collins D., Findlay K., Harding C. V. Processing of exogenous liposome-encapsulated antigen in vivo generated class I MHC-restricted T cell responses. J. Immunol. (1992); 148: 3336
   PubMed Web of Science ®Google Scholar
• Connor J. M., Yatvin M. B., Huang L. pH-sensitive liposomes: acid-induced liposome fusion. Proc. Natl. Acad. Sci. USA (1984); 81: 1715
   PubMed Web of Science ®Google Scholar
• Cresswell P., Blum J. S., Kelner D. N., Marks M. S. Biosynthesis and processing of class II histocompatibility antigens. Crit. Rev. Immunol. (1987); 7: 31
   PubMed Web of Science ®Google Scholar
• Dailey M. O., Post W., Hunter R. L. Induction of cell-mediated immunity to chemically modified-antigen in guinea pigs II: The interaction between lipid-conjugated antigens, macrophages and T cells. J. Immunol (1977); 118: 963
   PubMed Web of Science ®Google Scholar
• Dailey M. O., Pillemer E., Weissman I. L. Protection against syngeneic lymphoma by a long-lived cytotoxic T cell clone. Proc. Natl. Acad. Sci. USA (1984); 79: 5384
   Web of Science ®Google Scholar
• Dalsgaard K. A study of the isolation and characterization of the saponin Quil-A. Acta Vet. Scand. (1978); 19: 1, (suppl.)
   PubMedGoogle Scholar
• Debrick J. E., Campbell P. A., Staerz U. D. Macrophages as accessory cells for class I MHC-restricted immune responses. J. Immunol (1991); 147: 2846
   PubMed Web of Science ®Google Scholar
• Defoort J. P., Nardelli B., Huang W., Tarn J. P. Macromolecular assemblage in the design of a synthetic AIDS vaccine. Proc. Natl. Acad. Sci. USA (1992); 89: 3879
   PubMed Web of Science ®Google Scholar
• Degen E., Williams D. B. Participation of a novel 88-Kd protein in the biogenesis of murine class I MHC. J. Cell Biol (1991); 112: 1099
   PubMed Web of Science ®Google Scholar
• Degen E., Cohendoyle M. F., Williams D. B. Efficient dissociation of the p88 chaperon from MHC class I molecule requires both β2-microglobulin and peptide. J. Exp. Med. (1992); 175: 1653
   PubMed Web of Science ®Google Scholar
• Denkers E. Y., Giazzinelli R. T., Hieney S., Caspar P., Sher A. Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific CTL. J. Immunol (1993); 150: 517
   PubMed Web of Science ®Google Scholar
• Deres K., Schild H., Wiesmuller K-H., Jung G., Rammensee H. G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccines. Nature (1989); 342: 561
   PubMed Web of Science ®Google Scholar
• Dice J. F. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem. Sci. (1990); 15: 305
   PubMed Web of Science ®Google Scholar
• Donnelly J. J., Ulmer J. B., Hawe L. A., Friendman A., Shi X-P., Liu M. A. Targeted delivery of peptides to class I MHC molecules by a modified Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA (1993); 90: 3530
   PubMed Web of Science ®Google Scholar
• Driscoll J., Goldberg A. L. Skeleton muscle proteasome can degrade proteins in an ATP dependent process that does not require ubiquitin. Proc. Nat. Acad. Sci. U.S.A (1989); 86: 787
   PubMed Web of Science ®Google Scholar
• Duzgunes N., Straubinger R. M., Baldwin P., Papahadjapolous D. pH-sensitive liposomes: Introduction of foreign substance into cells. Membrane Fusion, J. Wilschut, D. Hoekstra, (1988); 713
   Google Scholar
• Eisenlohr L. C., Yewdell J. W., Bennink J. R. A transient transfection system for identifying biosynthesized proteins processed and presented to class I MHC restricted T lymphocytes. J. Immunol. Methods (1992); 154: 131
   PubMed Web of Science ®Google Scholar
• Ellens H., Bents J., Szoka E C. pH-induced destabilization of dioleoylphosphatidylethanolame-containing liposomes: role of bilayer contact. Biochemistry (1984); 23: 1532
   PubMed Web of Science ®Google Scholar
• Esquivel F., Yewdell J., Bennink J. RMA-S cells present endogenously synthesized cytosolic proteins to class I-restricted CTL. J. Exp. Med. (1992); 175: 163
   PubMed Web of Science ®Google Scholar
• Falo L. D., Colarusso L. J., Benacerraf B., Rock K. L. Serum proteases alter the antigenicity of peptides presented by class I MHC molecules. Proc. Natl. Acad. Sci. USA (1992); 89: 8347
   PubMed Web of Science ®Google Scholar
• Fan S. T., Edgington T. S. Sufficiency of the CD8+ T cell lineage to mount an effective tumoricidal response to syngeneic novel class I MHC antigens. J. Immunol (1989); 143: 4289
   Google Scholar
• Finberg R., Matthew M., Burakoff S. J. The induction of virus-specific CTL with solubilized viral and membrane proteins. J. Exp. Med. (1978); 148: 1620
   PubMed Web of Science ®Google Scholar
• Flexner C. New approaches to vaccination. Adv. Pharmacol (1990); 21: 51
   PubMedGoogle Scholar
• Gao X-M., Zheng B., Liew F. Y., Brett S., Tite J. Priming of influenza virus-specific cytotoxic T lymphocytes in vivo by short synthetic peptides. J. Immunol (1991); 147: 3268
   PubMed Web of Science ®Google Scholar
• Goldberg A. L., Rock K. L. Proteolysis, proteasomes and antigen presentation. Nature (1992); 357: 375
   PubMed Web of Science ®Google Scholar
• Grant E. P., Rock K. L. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo. J. Immunol (1992); 148: 13
   PubMed Web of Science ®Google Scholar
• Greenbergh P. D. Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytotoxic T cells can mediate eradication of disseminated leukemia. J. Immunol (1986); 136: 1917
   PubMed Web of Science ®Google Scholar
• Gregoriadis G., Tan L., Xiao Q. The immunoadjuvant action of liposomes: Role of structural characteristics. Immunoadjuvants, G. Gregoriadis, A. C. Allison, G. Poste. NATO Advance Study Institute (ASI) Series, Plenum Press. (1990); 79
   Google Scholar
• Gregoriadis G. Immunoadjuvants: a role for liposomes. Immunol Today (1990); 11: 89
   PubMedGoogle Scholar
• Hahn C. S., Hahn Y. S., Braciale T. J., Rice C. M. Infectious sindbis virus transient expression vectors for studying antigen processing and presentation. Proc. Natl. Acad. Sci. USA (1992); 89: 2679
   PubMed Web of Science ®Google Scholar
• Hamaoka T., Shimzu J., Suda T., Fujiwara H. Induction of tumor specific in vivo protective immunity by immunization with tumor antigen-paused antigen presenting cells. Immune System and Cancer, T. T Hamaoka, et al. Japan Sci. Soc. Press. Tokyo/Taylor & Francis LTD, London (1989); 265
   Google Scholar
• Harding C. V., Unanue E. R. Antigen processing and intracellular the la: possible roles of endocytosis and protein synthesis in the la function. J. Immunol (1989); 142: 12
   PubMed Web of Science ®Google Scholar
• Harding C. V., Collins D. S., Slot J. W., Geuze H. J., Unanue E. R. Liposome-encapsulated antigen are processed in lysosomes, recycled, and presented to T cells. Cell (1991); 64: 393
   PubMed Web of Science ®Google Scholar
• Harding C. V., Collins D. S., Kanagwa O., Unanue E. R. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol (1992a); 147: 2860
   Web of Science ®Google Scholar
• Harding C. V. Electroporation of exogenous antigen into the cytosol for antigen processing and class I MHC-restricted presentation: weak base amine and hypothermia (18°C) inhibit the class I MHC processing pathway. Eur. J. Immunol (1992b); 22: 1865
   PubMed Web of Science ®Google Scholar
• Harding F., McArthur J. G., Gross J. A., Paulet D. H., Allison J. P. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature (1992); 356: 607
   PubMed Web of Science ®Google Scholar
• Hart M. K., Weihold K. L., Scerce R. M., Washburn E. M., Clark C. A., Palker T. J., Haynes B. F. Priming of anti-human HIV CD8+ CTL in vivo by carrier free HIV synthetic peptides. Proc. Natl. Acad. Sci. USA (1991); 88: 9448
   PubMed Web of Science ®Google Scholar
• Heeg K., Kuon W., Wagner H. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide. Eur, J. Immunol. (1991); 21: 1523
   PubMed Web of Science ®Google Scholar
• Henderson R. A., Michel H., Sakguchi K., Shabanowitz J., Appella E., Hunt D. F., Engelhard V. H. HLA-A2.1 associated peptide from a mutant cell line: a secondary pathway of antigen presentation. Science (1992); 255: 1264
   PubMed Web of Science ®Google Scholar
• Hoffman M. Determining what immune cells see. Science (1992); 255: 531
   PubMed Web of Science ®Google Scholar
• Hosken N. A., Bevan M. J., Carbone F. R. Class I-restricted presentation occurs without internalization or processing of exogenous antigen peptides. J. Immunol (1989); 142: 1079
   PubMed Web of Science ®Google Scholar
• Hosken N., Bevan M. J. An endogenous antigen peptide bypass the class I antigen presentation defect in RMA-S. J. Exp. Med. (1992); 175: 719
   PubMed Web of Science ®Google Scholar
• Huang L. Liposome-mediated delivery to cells. Liposomes, M. J. Ostro. Marcel Dekker, Inc., New York (1983); 87
   Google Scholar
• Huang L., Reddy R., Nair S. K., Zhou F., Rouse B. T. Liposomal delivery of soluble protein antigens for class I MHC-mediated antigen presentation. Res. Immunol (1992); 143: 192
   PubMedGoogle Scholar
• Hui K. M., Sabapathy T. K., Oei A. A., Chia T. F. Generation of allo-reactive CTL by particle bombardment-mediated gene transfer. J. Immunol. Methods (1994); 171: 147
   PubMed Web of Science ®Google Scholar
• Hunt D. E., Henderson R. A., Shabanowitz J., Sakaguchi K., Engelhard V. H. Characterization of peptides bound to the class I MHC molecule HLA-A2 by mass spectrometry. Science (1992); 255: 1261
   PubMed Web of Science ®Google Scholar
• Ishioka G. Y., Colon S., Miles C., Grey H. M., Chesnut R. W. Induction of class I MHC-restricted, peptide-specific cytotoxic T lymphocytes by peptide priming in vivo. J. Immunol (1989); 143: 1094
   PubMed Web of Science ®Google Scholar
• Jenkins M. K., Ashwell J. D., Schwartz R. H. Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen presenting cell. J. Immunol. (1988); 140: 3324
   PubMed Web of Science ®Google Scholar
• Kast W. M., Roux L., Curren J., Blom H. J. J., Voordouw A. C., Melief C. J. M. Protection against lethal Sendai virus infection by in vivo priming of virus-specific T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA (1991); 88: 2283
   PubMed Web of Science ®Google Scholar
• Kawano H., Mifune K., Ohuchi M., Shichijo A. Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus. J. General Virol (1990); 71: 287
   Google Scholar
• Klarnet J. P., Matis L. A., Kern D. E., Mizuno M. T., Cheever M. A. Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia and provide specific immunologic memory. J. Immunol (1987); 138: 4012
   PubMed Web of Science ®Google Scholar
• Klibanov A. V., Levashov A. V., Alakhov V. Y. Lipid modification of proteins and their membrane transport. Protein Eng. (1989); 3: 39
   PubMedGoogle Scholar
• Krangel M. S., Orr H. T., Strominger J. L. Assembly and maturation of HLA-A and HLA-B antigens. Proc. Natl. Acad. Sci. U.S.A. (1979); 76: 2237
   Google Scholar
• Lafferty K. J., Anderus L., Prowse S. J. Role of lymphokine and antigen in the control of specific T cell responses. Immunol. Rev. (1980); 51: 279
   PubMed Web of Science ®Google Scholar
• Lawman M. J. P., Naylor P. T., Huang L., Courtney R. J., Rouse B. T. Cell-mediated immunity to Herpes Simplex Virus: Induction of CTL response by viral antigens incorporated into liposomes. J. Immunol (1980); 126: 304
   Web of Science ®Google Scholar
• Ljunggren H-G., Stam N. J., Ohlen C., Neefjes J. J., Townsend A., Ploegh H. L. Empty MHC class I molecules come out in the cold. Nature (1990); 346: 476
   PubMed Web of Science ®Google Scholar
• Lipford G. B., Lehn N., Bavier S., Heeg K., Wagner H. The immunodominant peptides from Listeriolysin in Quil A liposomes vaccines CD8+ cytolytic T cells and confers protection to infection. Immunology (1994a); 40: 101
   Web of Science ®Google Scholar
• Lipford G. B., Wagner H., Heeg K. Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine (1994b); 12: 73
   PubMed Web of Science ®Google Scholar
• Lopes L. M., Chain B. M. Liposome-mediated delivery stimulates a class I-restricted cytotoxic T cell response to soluble antigen. Eur. J. Immunol (1992); 22: 287
   PubMed Web of Science ®Google Scholar
• Lotteau V., Teyton L., Peleraux A., Nilsson T., Peterson P. A. Intracellular transport of class II MHC molecules directed by invariant chain. Nature (1990); 348: 600
   PubMed Web of Science ®Google Scholar
• Loveland B., Wang C. R., Yonekawa H., Hermel E., Hindahl K. F. Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell (1990); 60: 971
   PubMed Web of Science ®Google Scholar
• Luescher I. F., Loez J. A., Malissen B., Cerottini J-C. Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling. J. Immunol (1992); 148: 1003
   PubMed Web of Science ®Google Scholar
• Lukacher A. E., Braciale V. L., Braciale T. J. In vivo effecter function of influenza viral specific CTL clone is highly specific. J. Exp. Med. (1984); 160: 814
   PubMed Web of Science ®Google Scholar
• Machy P., Truneh A. Differential halflife of MHC class I molecules in T and B lymphoblasts. Mol. Immunol (1989); 26: 687
   PubMed Web of Science ®Google Scholar
• Malnati M. S., Marti M., Lavante T., Jaraquemada D., Biddison W., Demars R., Long E. O. Processing pathway for presentation of cytosolic antigen to class II-restricted T cells. Nature (1991); 375: 702
   Google Scholar
• Maloy K. J., Donachie A. M., O'Hagan D. T., McMowat A. I. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly (lactide-co-glycolide) microparticles. Immunology (1994); 81: 661
   PubMed Web of Science ®Google Scholar
• Matsumura M., Fremord D. H., Peterson P. A., Wilson I. A. Emerging principle for the recognition of peptide antigens by MHC class I molecules. Science (1992); 257: 927
   PubMed Web of Science ®Google Scholar
• Mbawuike I. N., Wyde P. R. Induction of CD8+ CTL by immunization with killed virus and effect of cholera toxin B subunit. Vaccine (1993); 11: 1206
   Google Scholar
• Michalek M. T., Benacerraf B., Rock K. L. Weak base amines can inhibit class I MHC-restricted antigen presentation. J. Immunol (1991); 146: 449
   PubMed Web of Science ®Google Scholar
• Miller M. D., Gould-Fogerite S., Shen L., Woods R. M., Koenig S., Mannino R. J., Letvin N. L. Vaccination of rhesus monkeys with synthetic peptides in a fusogenic proteoliposomes elicits SIV CD8+ CTL. J. Exp. Med. (1992); 176: 1739
   PubMed Web of Science ®Google Scholar
• Momburg F., Ortiz-Navarrete V., Neefjes J., Spits N., Walden P., Hammerling G. Proteasome subunits encoded by the MHC are not essential for antigen presentation. Nature (1992); 360: 174
   PubMed Web of Science ®Google Scholar
• Moore M. W., Carbone F. R., Bevan M. J. Introduction of soluble proteins into the class I pathway of antigen processing and presentation. Cell (1988); 54: 777
   PubMed Web of Science ®Google Scholar
• Morein M. The iscom antigen-presenting system. Nature (1988); 332: 287
   PubMed Web of Science ®Google Scholar
• Morrison L. A., Lukacher A. E., Braciale V. L., Fan D. P., Braciale T. J. Difference in antigen presentation to MHC class I and class II restricted influenza virus specific CTL clones. J. Exp. Med. (1986); 163: 903
   PubMed Web of Science ®Google Scholar
• Morrison L. A., Braciale V. L., Braciale T. J. Antigen form influences induction and frequency of influenza-specific class I and class II MHC restricted cytotoxic T lymphocytes. J. Immunol (1988); 141: 363
   PubMed Web of Science ®Google Scholar
• Moss B., Flexner C. Vaccinia virus expression vectors. Ann. Rev. Immunol (1987); 5: 305
   PubMed Web of Science ®Google Scholar
• Moss B. Vaccinia virus: a tool for research and vaccine development. Science (1991); 252: 1662
   PubMed Web of Science ®Google Scholar
• Murray N., McMichael A. Antigen presentation in virus infection. Current Opinion Immunol (1992); 4: 401
   PubMed Web of Science ®Google Scholar
• Nabel E. G., Plautz G., Nabel G. J. Transduction of a foreign histocompatibility gene into the arterial wall induce vasculitis. Proc. Natl. Acad. Sci. USA (1990); 89: 5157
   Web of Science ®Google Scholar
• Nair S., Zhou F., Reddy R., Huang L, Rouse B. T. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte response in vitro. J. Exp. Med. (1992a); 175: 609
   PubMed Web of Science ®Google Scholar
• Nair S., Zhou X., Huang L., Rouse B. T. Class I-restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines. J. Immunol. Methods (1992b); 152: 237
   PubMed Web of Science ®Google Scholar
• Nakayama E., Uenaka A. Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection. J. Exp. Med. (1985); 161: 345
   PubMed Web of Science ®Google Scholar
• Neefjes J. J., Stollorz V., Peters P. J., Geuze H. J., Ploegh H. L. The biosynthetic pathway of MHC class II molecules but not class I molecules intersects the endocytic route. Cell (1990); 61: 171
   PubMed Web of Science ®Google Scholar
• Neefjes J. J., Ploegh H. L. Allele and locus-specific difference in association of MHC class I H chain with β2-microglobulin and surface expression. Eur. J. Immunol. (1988); 18: 801
   PubMed Web of Science ®Google Scholar
• Newman M. J., Wu J. Y., Gardner B. H., Munroe K. J., Coughlin R. T. Saponin adjuvant induction of ovalbumin-specific CD8+ CTL responses. J. Immunol (1992); 148: 2357
   PubMed Web of Science ®Google Scholar
• Noguchi Y., Noguchi T., Sato T., Yokoo Y., Shiku H. Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related proteins reconstituted into liposomes. J. Immunol. (1991); 146: 3599
   PubMed Web of Science ®Google Scholar
• Nuchtern J. G., Bonifacino J. S., Biddison W. E., Klausner R. D. Brefeldin A implicates egress from ER in class I-restricted antigen presentation. Nature (1989); 339: 223
   PubMed Web of Science ®Google Scholar
• Ohlen C., Bastin J., Ljunggren H-G. Resistance to H-2 restricted but not allo H-2 specific graft and CTL response. J. Immunol (1990); 145: 52
   PubMed Web of Science ®Google Scholar
• Okada C. Y., Rechsteiner M. Introduction of macro-molecules into the culture mammalian cells by osmotic lysis of pinosome vesicles. Cell (1982); 29: 33
   PubMed Web of Science ®Google Scholar
• Otten G. R., Bikoff E., Ribaudo R. K., German R. N. Peptides and β2-microglobulin regulation of cell surface MHC class I conformation and expression. J. Immunol (1992); 148: 3723
   PubMed Web of Science ®Google Scholar
• Parham P. Transporters of delight. Nature (1990); 348: 674
   PubMed Web of Science ®Google Scholar
• Parish C. R. Immune response to chemical modified flagellin. II. Evidence for fundamental relationship between humoral and cell-mediated immunity. J. Exp. Med. (1971); 134: 2
   Google Scholar
• Perkins D. L., Lai M-Z., Smith J. A., Gefter M. Identical peptides recognized by MHC class I and class II restricted T cells. J. Exp. Med. (1989); 170: 279
   PubMed Web of Science ®Google Scholar
• Peters P. J., Neefjes J. J., Oorschot V., Ploegh H. L., Geuze H. J. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature (1991); 349: 669
   PubMed Web of Science ®Google Scholar
• Pfeifer J. D., Wick M. J., Roberts R. L., Findly K., Normak S. J., Harding C. V. Phagocytic processing of bacterial antigen for class I MHC presentation to T cells. Nature (1993); 361: 359
   PubMed Web of Science ®Google Scholar
• Phillips N. C., Major P. P., Sikorska H. Tumor-associated antigens as immunotherapy targets. Cancer Detect. Prevent. (1988); 12: 451
   PubMedGoogle Scholar
• Raychaudhuri S., Tonks M., Carbone F., Ryskamp T., Morrow W. J. W., Hanna N. Induction of antigen-specific class I-restricted CTL by soluble proteins in vivo. Proc. Natl. Acad. Sci. USA (1992); 89: 8303
   PubMedGoogle Scholar
• Reddy R., Zhou F., Huang L., Rouse B. T. pH-sensitive liposomes provide an efficient means of sensitizing target cells to class I-restricted CTL recognition of soluble proteins. J. Immunol Methods (1991); 141: 157
   PubMed Web of Science ®Google Scholar
• Reddy R., Zhou F., Nair S., Huang L., Rouse B. T. In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J. Immunol (1992); 148: 1585
   PubMed Web of Science ®Google Scholar
• Reid G. Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid. Vaccine (1992); 10: 597
   PubMed Web of Science ®Google Scholar
• Resfifo N. P., Spess P. J., Karp S. E., et al. A non-immunogenic sarcoma transduced with the cDNA for INF-γ elicits CD8+ T cells against the wild type tumor correlates with antigen presentation capacity. J. Exp. Med. (1992); 175: 1423
   PubMedGoogle Scholar
• Richards R. L., Swartz G. M., Jr., Schultz C., Alving C. R. Immunogenicity of malaria sporozoite antigen in monkeys: Adjuvant effect of aluminum hydroxide and non-pyrogenic MPL. Vaccine (1989); 7: 506
   PubMed Web of Science ®Google Scholar
• Rock K. L., Gamble S., Rothstein L. Presentation of exogenous antigen with class MHC molecules. Science (1990); 249: 918
   PubMed Web of Science ®Google Scholar
• Rock K. L., Gamble S., Rothstein L., Gramm C., Benacerraf B. Dissociation of [β2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface. Cell (1991); 65: 611
   PubMed Web of Science ®Google Scholar
• Rock K. L., Rothstein L., Gamble S., Fleischacker C. Characterization of APC that present exogenous antigen in association with class I MHC molecules. J. Immunol (1993); 147: 2846
   Google Scholar
• Russell S. J., Eccles S. A., Fleming C. L., et al. Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of IL-2 cDNA. Int. J. Cancer (1991); 47: 244
   PubMed Web of Science ®Google Scholar
• Sadoff J. C., Ballon W. R., Baron L. S., et al. Oral Salmonella Typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science (1988); 240: 336
   PubMed Web of Science ®Google Scholar
• Schafer R., Porrnoy D. A., Brassell S. A., Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria Monocytogen vaccine. J. Immunol. (1992); 149: 53
   PubMed Web of Science ®Google Scholar
• Schild H., Deres K., Wiesmuller K-H., Jung G., Rammensee H. G. Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. Eur. J. Immunol (1991); 21: 2469
   PubMedGoogle Scholar
• Sherman L. A., Burke T. A., Biggs J. A. Extracellular processing of peptides that bind class I MHC molecules. J. Exp. Med. (1992); 175: 1221
   PubMed Web of Science ®Google Scholar
• Schulz M., Zinkernagel R. M., Hengartner H. Peptide induced antiviral protection by cytotoxic T cells. Proc. Natl Acad. Sci. USA (1991); 88: 991–3
   PubMed Web of Science ®Google Scholar
• Sijts A., De Brijn M., Nieland J., Kast W. M., Melief C. Cytotoxic T lymphocytes against antigen-processing-defective RMA-S tumor cell line. Eur. J. Immunol (1992); 23: 1639
   Google Scholar
• Smith J. D., Lie W-R., Gorka J., Myers N. B., Hansen T. H. Extensive peptide exchange by surface class I MHC molecules independent of exogenous β2-microglobulin. Proc. Natl. Acad. Sci. USA (1992); 89: 7767
   PubMed Web of Science ®Google Scholar
• Spies T., Cerundolo V., Colonna M., Cresswell P., Townsend A., De Mars R. Presentation of endogenous viral antigen dependent on putative peptide transporter heterodimer. Nature (1992); 355: 644
   PubMed Web of Science ®Google Scholar
• Srivastava P. K., Udono H., Blachere N. E., Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming (review). Immunogenetics (1994); 39: 93
   PubMed Web of Science ®Google Scholar
• Staerz U. D., Karasuyama H., Garner A. M. Cytotoxic lymphocytes against a soluble protein. Science (1987); 329: 449
   Google Scholar
• Straubinger R. M., Duzgunes N., Papahadjapolous D. pH-sensitive liposomes mediated cytoplasmic delivery of encapsulated macromolecules. FEBS Lett. (1985); 179: 148
   PubMed Web of Science ®Google Scholar
• Storkus W. J., Zeh H. J., Falter R. D., Lotze M. T. Identification of T cell epitopes: rapid isolation of class I-presented peptide from viable cells by mild acid elution. J. Immunol. Ther. (1993); 14: 94
   PubMed Web of Science ®Google Scholar
• Sundquist B., Lovgren K., Morein B. Antiviral activity of iscom-antigen. Vaccine (1988); 6: 49
   PubMed Web of Science ®Google Scholar
• Takahashi H., Takeshita T., Morein B., Putney S., Germain R. N., Berzofsky J. A. Induction of CD8+ cytotoxic T lymphocytes by immunization with purified HIV-1 envelop proteins in ISCOMs. Nature (1990); 344: 873
   PubMed Web of Science ®Google Scholar
• Tite J. P. Differential requirement for protein synthesis in the cytolysis mediated by class I and class II MHC restricted CTL. Immunol (1990); 70: 440
   PubMed Web of Science ®Google Scholar
• Townsend A. R.M., Gotch F. M., Dovey J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell (1985); 42: 457
   PubMed Web of Science ®Google Scholar
• Townsend A., Bastin J., Gould K., Brownlee G., Andrew M., Smith G. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia infected cells is overcome by enhanced degradation of Antigen. J. Exp. Med. (1988); 18: 1211
   Google Scholar
• Townsend A., Ohlen C., Bastin J., et al. Association of class I MHC heavy and light chains induced by viral peptides. Nature (1989); 340: 443
   PubMed Web of Science ®Google Scholar
• Townsend A. Antigen processing: A new presentation pathway?. Nature (1992); 356: 367
   PubMedGoogle Scholar
• Townsend S. E., Allison J. P. Tumor rejection after co-stimulation of CD8+ T cells by B7 transfected melanoma cells. Nature (1993); 259: 368
   Google Scholar
• Ulmer J. B., Donnelly J. J., Parker S. E., Rhodes G. H., Feigner P. L., Liu M. A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993); 259: 1745
   PubMed Web of Science ®Google Scholar
• Van Binnendijk R. S., Van Baalen C. A., Poelen M. C.M., et al. Measles virus transmembrane fusion protein synthesized do nova or presented in iscom is endogenously processed for HLA class I and class II-restricted CTL recognition. J. Exp. Med. (1992); 176: 119
   PubMed Web of Science ®Google Scholar
• Van Rooijen N. Liposomes as carrier and immunoadjuvant of vaccine antigen. Bacterial Vaccines. Alan R. Liss, Inc. (1990); 255
   Google Scholar
• Van Rooijen N. Antigen processing and presentation in vivo: The micro-environment as a crucial factor. Immunol. Today (1990); 11: 436
   PubMedGoogle Scholar
• Van Rooijen N., Kors N., Ende V.D.M., Dijkstra C. D. Depletion and repopulation of macrophages in the spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res. (1990); 260: 215
   PubMed Web of Science ®Google Scholar
• Varsanyi T., Morein B., Love A., Norrby E. Protection against lethal measles virus infection in mice by iscom containing the haemagglutinin or fusion proteins. J. Virol. (1987); 61: 3896
   PubMed Web of Science ®Google Scholar
• Vega M. A., Strominger J. L. Constitutive endocytosis of HLA class I antigen requires a specific portion of the intra-cytoplasmic tail that shares structural features with other endocytosed molecules. Proc. Natl. Acad. Sci. USA (1987); 86: 2688
   Web of Science ®Google Scholar
• Verma J. N., Wassef N. M., Wirtz R. A., Atkinson C. T., Aikawa M., Loomis L. D., Alving C. R. Phagocytosis of liposomes by macrophages: Intracellular fate of liposomal malaria antigen. Biochim. Biophys. Acta (1991); 1066: 229
   PubMed Web of Science ®Google Scholar
• Viani P., Cervato G., Gatti P., Cestaro B. Plasma dependent pH sensitivity of liposomes containing sulfatide. Biochim. Biophys. Acta (1993); 1147: 73
   PubMed Web of Science ®Google Scholar
• Walden P., Nagy Z. A., Klein J. Induction of regulatory T lymphocyte responses by liposome carrying MHC molecules and foreign antigen. Nature (1985); 315: 327
   PubMed Web of Science ®Google Scholar
• Walker C., Selby M., Erickson A., Cataldo D., Valensi J-P., Nest G. V. Cationic lipids direct a viral glycoprotein into the class I MHC antigen presenting pathway. Proc. Natl. Acad. Sci. USA (1992); 89: 7915
   PubMed Web of Science ®Google Scholar
• Wallny H. J., Rammensee H. G. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature (1990); 343: 275
   PubMed Web of Science ®Google Scholar
• Wang C. Y., Huang L. Plasmid DNA adsorbed to pH-sensitive liposomes efficiently transforms the target cells. Biochem. Biophys. Res. Commun. (1987); 147: 980
   PubMed Web of Science ®Google Scholar
• Watson D. L., Watson N. A., Fossum C., Lovgren K., Morein B. Interactions between immune-stimulating complexes (iscoms) and peritoneal mononuclear leukocytes. Microbial. Immunol. (1992); 36: 199
   PubMed Web of Science ®Google Scholar
• Weaver C., Unanue E. R. The co-stimulatory function of antigen presenting cells. Immunol. Today (1990); 11: 49
   PubMedGoogle Scholar
• Wei M. L., Cresswell P. HLA-A2 molecules in an antigen processing mutant cell contain signal sequence-derived peptides. Nature (1992); 356: 443
   PubMed Web of Science ®Google Scholar
• Weiss S., Bogen B. MHC class II-restricted presentation of intracellular antigen. Cell (1991); 64: 767
   PubMed Web of Science ®Google Scholar
• Wu Y., Liu Y. Viral induction of co-stimulatory activity on antigen presenting cells bypass the need for CD4+ T cell help in CD8+ T cell response. Current Biol (1994); 4: 499
   PubMed Web of Science ®Google Scholar
• Wu J-Y., Gardner B. H., Murphy C. I., Seals J. A., Newman M. J. Saponin adjuvant enhancement of antigen-specific immune response to an experimental HIV vaccine. J. Immunol. (1992); 148: 1519
   PubMed Web of Science ®Google Scholar
• Yewdell J. W., Bennink J. R., Hosaka Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science (1988); 239: 637
   PubMed Web of Science ®Google Scholar
• Zhou F., Rouse B. T., Huang L. An Improved method of loading pH-sensitive liposomes with soluble proteins for class I-restricted antigen presentation. J. Immunol. Methods (1991); 145: 143
   PubMed Web of Science ®Google Scholar
• Zhou F., Rouse B. T., Huang L. Induction of cytotoxic T lymphocytes in vivo with soluble protein antigen entrapped in membranous vehicles. J. Immunol. (1992a); 149: 1599
   PubMed Web of Science ®Google Scholar
• Zhou F., Rouse B. T., Huang L. Prolonged survival of thymoma-bearing mice after vaccination with a soluble antigen in liposomes: A model study. Cancer Res. (1992b); 52: 6287
   PubMed Web of Science ®Google Scholar
• Zhou F. MHC class I-restricted presentation of protein antigen delivered by liposomes. Dissertation, University of Tennessee, Knoxville, TN 1992c
   Google Scholar
• Zhou F, Huang L. Monophosphoryl lipid A can enhances specific CTL induction by liposomal antigens. Vaccine (1993); 11: 1139
   PubMed Web of Science ®Google Scholar
• Zhou F., Watkins C., Huang L. Characterization and kinetics of MHC class I-restricted presentation of soluble antigen delivered by liposomes. Immunobiol. (1994); 190: 35
   PubMed Web of Science ®Google Scholar
• Zhou X., Berg L., Abdel Motal U. M., Jondal M. In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. J. Immunol. Methods (1992); 153: 193
   PubMed Web of Science ®Google Scholar